Case Reports in Obstetrics and Gynecology / 2015 / Article / Fig 3

Case Report

Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination

Figure 3

Immunohistochemical study for (a, b) seromucinous tumor, (c, d) clear cell carcinoma, and (e, f) polypoid endometriosis. Estrogen receptor: (a), (c), and (e). Napsin A: (b), (d), and (f). Seromucinous tumor cells and endometriosis cells are positive for estrogen receptor (a, e) but negative for Napsin A (b, f). Clear cell carcinoma cells are positive for Napsin A (d) but negative for estrogen receptor (c).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.